Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Neurocognitive Resources
Booklet Neurobiology

Booklet Neurobiology

Published Date March 24, 2020

Download PDF

Neurobiology Services

Explore

Previous Article

Moving beyond amyloid to treat Alzheimer's disease

Beta-amyloid peptid. The amyloid precursor protein being cleaved by gamma and beta secretases and releasing the amyloid beta peptide, which can accumulate to amyloid plaques, one of the main...
Next Article

The Versatile Mouse Model for Rare Disease Research

More than 7,000 rare (or orphan) diseases have been described so far and affect over 350 million people worldwide. Unfortunately, less than 10% of these diseases have an approved treatment, and...

Other content in this Stream

over 3 years ago
MODEL-AD: Creating new mouse models for late-onset Alzheimer’s disease

Watch Video
over 3 years ago
MiceTech Talk Episode 22: Let’s Talk Exploring Neurobiology Solutions (Oct. 27, 2020)

October 27, 2020 - In this episode, we share with you highlights of JAX preclinical research studies using mouse models for ALS, Rett Syndrome, Friedreich's Ataxia, and more!

Watch Video
almost 4 years ago
MiceTech Talk Episode 12: Let's Talk Latest Advances in Alzheimer's Disease Research (Aug. 4, 2020)

August 4, 2020 - We highlight some of the latest studies and discoveries presented at the AAIC Conference, the most influential international meeting dedicated to advancing dementia science.

Watch Video
almost 4 years ago
Moving beyond amyloid to treat Alzheimer's disease

Beta-amyloid peptid. The amyloid precursor protein being cleaved by gamma and beta secretases and releasing the amyloid beta peptide, which can accumulate to amyloid plaques, one of the main...

Learn More
almost 5 years ago
The Versatile Mouse Model for Rare Disease Research

More than 7,000 rare (or orphan) diseases have been described so far and affect over 350 million people worldwide. Unfortunately, less than 10% of these diseases have an approved treatment, and...

Learn More
over 5 years ago
600 trillion synapses and Alzheimers disease

Late-onset Alzheimer’s disease is extremely difficult to model in the laboratory, one reason why no successful therapy for it exists. But scientists are using new capabilities to create more...

Learn More
over 5 years ago
Investigating Stroke Therapeutic Targets Using JAX Aged C57BL/6J Mice

Introduction The brain is a highly complex organ comprised of a large number of cells and molecules, each with its own unique function. Diseases that affect the central nervous system (CNS), such...

Learn More
almost 8 years ago
Can I Outrun Alzheimer's Disease?

This is the third in a series about my genome sequence. I’ve already posted about my general thoughts and a conversation with a genetic counselor. Below I focus on the ApoE4 gene, the one...

Learn More
about 8 years ago
Alzheimer's disease and the complex puzzle of degeneration

Alzheimer’s disease is frightening. Incurable, progressive, burdensome and still biologically mysterious, it afflicts primarily the elderly and inexorably degenerates the brain tissue of patients....

Learn More

Return to Home